Miki Horiguchi

Biography

Publications

• Frequency and clinical features of germline pathogenic variants in sarcoma: a case-control study.

  Rodriguez-Hernandez A, Horiguchi M, Horton C, Polfus LM, Bychkovsky BL, Buehler RM, George S, Merriam P, Garber JE, Rana HQ. J Natl Cancer Inst 2026 Jan 01

  PMID: 41092038

• SMARCA4 pathogenic variants: Gynecological cancer histories from a laboratory tested cohort.

  Borden BA, Rodriguez-Hernandez A, Trottier M, Horiguchi M, Weyandt JD, Horton C, Polfus LM, Bychkovsky BL, Young CC, Garber JE, St Laurent JD, Rana HQ. Gynecol Oncol 2025

  PMID: 41086671

• Causes of Death Among Individuals With Lynch Syndrome in the Immunotherapy Era.

  Maoz A, Biller L, Giannakis M, Rubinson D, Jayakrishnan T, Horiguchi M, Ukaegbu C, Caruso A, Syngal S, Yurgelun MB. JCO Precis Oncol 2025

  PMID: 41075302

• Comment on "Average Hazard as Harmonic Mean" by Chiba (2025).

  Uno H, Tian L, Horiguchi M, Hattori S. Pharm Stat 2025 Sep-Oct

  PMID: 40775674

• A Novel Stratified Analysis Method for Testing and Estimating Overall Treatment Effects on Time-To-Event Outcomes Using Average Hazard With Survival Weight.

  Qian Z, Tian L, Horiguchi M, Uno H. Stat Med 2025 Mar 30

  PMID: 40213923